The journey of drug development is extensive and meticulously overseen. Before a drug's entrance into the market, it goes through several stages of clinical evaluation to assess its safety and effectiveness. Throughout this phase, oversight of safety is persistent and methodical. A pivotal document that supports this oversight is the Development Safety Update Report (DSUR). For those studying regulatory documentation, clinical research, or drug safety monitoring, grasping the